Symbollon Pharmaceuticals Announces Third Quarter 2006 Results
15th Nov 2006, 03:53 GMT
Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) today announced financial results for the third quarter ended September 30, 2006. For the three months ended September 30, 2006, the Company reported a...
Symbollon Pharmaceuticals Announces Third Quarter 2006 Results related news:
- Symbollon Pharmaceuticals, Inc.: Symbollon Pharmaceuticals Announces Third Quarter 2006 Results — Market Wire - Pharmaceuticals and Biotech
- Ligand Pharmaceuticals Announces Conference Call on Third Quarter Financial Results — RedOrbit News - Health
- Inflazyme Pharmaceuticals Ltd.: Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006 — Market Wire - Pharmaceuticals and Biotech
- Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006 — ArriveNet : Health
- Idera Pharmaceuticals Announces Financial Results for the 3 and 9 Months Ended 9/30/2006 — Operations-Related News from StratCenter.com
- Crucell N.V.: Crucell Announces Third Quarter 2006 Results — Market Wire - Pharmaceuticals and Biotech
- Canbras Announces Third Quarter 2006 Results — ArriveNet : Technology
- Ambrilia Biopharma Inc.: Ambrilia Announces Third Quarter 2006 Results and Provides Update on Lead Development Programs — Market Wire - Pharmaceuticals and Biotech
- Cordia Corporation Announces Financial Results for the Third Quarter of 2006 — VoIP Developer
- IdleAire Technologies Corporation Announces Third Quarter 2006 Operating Results - Third quarter revenues increased by 133% to $4.7 million — mysan.de - Lifestyle News
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL